Nu Skin Enterprises (NUS) 10-Q 30 Apr 19 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	Apr. 23, 2019
Entity Information [Line Items]
Entity Registrant Name	NU SKIN ENTERPRISES INC
Entity Central Index Key	0001021561
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Common Class A [Member]
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		55,486,600

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 310,288	$ 386,911
Current investments	8,038	11,346
Accounts receivable	57,390	53,282
Inventories, net	304,311	295,821
Prepaid expenses and other	67,655	51,877
Total current assets	747,682	799,237
Property and equipment, net	445,605	464,535
Right-of-use assets	117,329	0
Goodwill	196,573	196,573
Other intangible assets, net	86,935	89,989
Other assets	160,977	144,112
Total assets	1,755,101	1,694,446
Current liabilities:
Accounts payable	52,273	47,617
Accrued expenses	304,770	322,583
Current portion of long-term debt	45,000	69,455
Total current liabilities	402,043	439,655
Operating lease liabilities	81,075	0
Long-term debt	356,247	361,008
Other liabilities	104,541	111,916
Total liabilities	943,906	912,579
Commitments and contingencies (Note 11)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	553,270	552,564
Treasury stock, at cost - 35.0 million and 35.2 million shares	(1,325,251)	(1,326,605)
Accumulated other comprehensive loss	(75,794)	(79,934)
Retained earnings	1,658,879	1,635,751
Total stockholders' equity	811,195	781,867
Total liabilities and stockholders' equity	$ 1,755,101	$ 1,694,446

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares shares in Millions	Mar. 31, 2019	Dec. 31, 2018
Stockholders' equity:
Common stock, shares authorized (in shares)	500	500
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	35	35.2

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Consolidated Statements of Income (Unaudited) [Abstract]
Revenue	$ 623,623	$ 616,219
Cost of sales	146,664	146,281
Gross profit	476,959	469,938
Operating expenses:
Selling expenses	249,708	257,702
General and administrative expenses	158,598	153,246
Total operating expenses	408,306	410,948
Operating income	68,653	58,990
Other income (expense), net	(2,848)	1,207
Income before provision for income taxes	65,805	60,197
Provision for income taxes	22,803	24,658
Net income	$ 43,002	$ 35,539
Net income per share (Note 6):
Basic (in dollars per share)	$ 0.78	$ 0.66
Diluted (in dollars per share)	$ 0.77	$ 0.64
Weighted-average common shares outstanding:
Basic (in shares)	55,436	53,997
Diluted (in shares)	56,128	55,959

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Consolidated Statements of Comprehensive Income (Unaudited) [Abstract]
Net income	$ 43,002	$ 35,539
Other comprehensive income, net of tax:
Foreign currency translation adjustment, net of taxes of $(145) and $854 for the three months ended March 31, 2019 and 2018, respectively	4,140	11,047
Net unrealized gains/(losses) on foreign currency cash flow hedges, net of taxes of zero and $28 for the three months ended March 31, 2019 and 2018, respectively	0	(247)
Reclassification adjustment for realized losses/(gains) in current earnings, net of taxes of zero and $(5) for the three months ended March 31, 2019 and 2018, respectively	0	44
Total other comprehensive income	4,140	10,844
Comprehensive income	$ 47,142	$ 46,383

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Other comprehensive income, net of tax:
Foreign currency translation adjustment, tax	$ (145)	$ 854
Net unrealized gains/(losses) on foreign currency cash flow hedges, tax	0	28
Reclassification adjustment for realized losses/(gains) in current earnings, tax	$ 0	$ (5)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]Class A [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total
Stockholders' Equity [Roll Forward]
Cumulative effect adjustment from adoption of ASU | ASC 606 [Member]	$ 0	$ 0	$ 0	$ 0	$ (13,042)	$ (13,042)
Balance at beginning of period at Dec. 31, 2017	91	466,349	(1,304,694)	(66,318)	1,609,168	704,596
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	35,539	35,539
Other comprehensive income, net of tax	0	0	0	10,844	0	10,844
Repurchase of Class A common stock (Note 6)	0	0	(17,386)	0	0	(17,386)
Exercise of employee stock options/vesting of stock awards	0	(3,199)	3,498	0	0	299
Stock-based compensation	0	6,761	0	0	0	6,761
Business Acquisitions (1.4 million shares)	0	76,584	18,109	0	0	94,693
Equity component of convertible note settlement (net)	0	(23,262)	19,887	0	0	(3,375)
Cash dividends	0	0	0	0	(19,801)	(19,801)
Balance at end of period at Mar. 31, 2018	91	523,233	(1,280,586)	(55,474)	1,611,864	799,128
Stockholders' Equity [Roll Forward]
Cumulative effect adjustment from adoption of ASU | ASC 842 [Member]	0	0	0	0	657	657
Balance at beginning of period at Dec. 31, 2018	91	552,564	(1,326,605)	(79,934)	1,635,751	781,867
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	43,002	43,002
Other comprehensive income, net of tax	0	0	0	4,140	0	4,140
Repurchase of Class A common stock (Note 6)	0	0	(825)	0	0	(825)
Exercise of employee stock options/vesting of stock awards	0	(4,335)	2,179	0	0	(2,156)
Stock-based compensation	0	5,041	0	0	0	5,041
Cash dividends	0	0	0	0	(20,531)	(20,531)
Balance at end of period at Mar. 31, 2019	$ 91	$ 553,270	$ (1,325,251)	$ (75,794)	$ 1,658,879	$ 811,195

Consolidated Statements of St_2

Consolidated Statements of Stockholder's Equity (Parenthetical) - shares shares in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Stockholders' Equity [Roll Forward]
Exercise of employee stock options (in shares)	0.2	0.3
Business acquisitions (in shares)		1.4

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 43,002	$ 35,539
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	19,607	18,907
Equity method earnings	0	(456)
Gain on step acquisitions	0	(13,644)
Loss on extinguishment of debt	0	7,220
Foreign currency losses	458	1,764
Stock-based compensation	5,041	6,761
Deferred taxes	1,668	10,062
Non-cash lease expense	11,375	0
Changes in operating assets and liabilities:
Accounts receivable	(4,145)	(8,589)
Inventories, net	(7,271)	(6,624)
Prepaid expenses and other	(15,540)	(12,915)
Other assets	(180)	(974)
Accounts payable	5,157	2,179
Accrued expenses	(68,842)	(36,230)
Other liabilities	1,484	(4,113)
Net cash provided by operating activities	(8,186)	(1,113)
Cash flows from investing activities:
Purchases of property and equipment	(13,765)	(12,652)
Proceeds on investment sales	7,444	7,781
Purchases of investments	(4,321)	(4,539)
Acquisitions and investments in equity investees	(7,500)	(33,061)
Net cash used in investing activities	(18,142)	(42,471)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	(2,156)	299
Payments of debt	(134,455)	(9,094)
Payment of cash dividends	(20,531)	(19,801)
Proceeds from debt	105,000	75,943
Repurchases of shares of common stock	(825)	(17,386)
Net cash used in financing activities	(52,967)	29,961
Effect of exchange rate changes on cash	2,672	8,708
Net increase (decrease) in cash and cash equivalents	(76,623)	(4,915)
Cash and cash equivalents, beginning of period	386,911	426,399
Cash and cash equivalents, end of period	$ 310,288	$ 421,484

The Company

The Company	3 Months Ended
	Mar. 31, 2019
The Company [Abstract]
The Company	1. The Company Nu Skin Enterprises, Inc. (the “Company”) is a holding company, with Nu Skin, a leading, global direct selling company, being the primary operating unit. Nu Skin develops and distributes premium-quality, innovative personal care products and nutritional supplements that are sold worldwide under the Nu Skin and Pharmanex brands and a small number of other products and services. Over the last several years, Nu Skin has introduced new Pharmanex nutritional supplements and Nu Skin personal care products under its ageLOC

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2019
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information as of March 31, 2019, and for the three-month periods ended March 31, 2019 and 2018. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December 31, 2018 has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) In February 2016, the FASB issued ASU 2016-02, Leases In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This guidance simplifies the required test of goodwill for impairment by eliminating Step 2 from the goodwill impairment test. If a company determines in Step 1 of the goodwill impairment test that the carrying value of a reporting unit is less than the fair value, an impairment in that amount should be recorded to the income statement, rather than proceeding to Step 2. This ASU is effective for interim and annual impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted. The Company has elected to early adopt the new standard effective January 1, 2019. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. In December 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities This ASU was effective for the Company beginning on January 1, 2019. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. In February 2018, the FASB issued ASU 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The Company has elected to early adopt the standard effective October 1, 2018. The cumulative impact of adoption was a $1.7 million net reduction to beginning retained earnings. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. Inventory Inventories consist of the following (U.S. dollars in thousands): March 31, 2019 December 31, 2018 Raw materials $ 89,984 $ 91,610 Finished goods 214,327 204,211 Total Inventory, net $ 304,311 $ 295,821 Revenue Recognition Adoption of ASC Topic 606, “Revenue from Contracts with Customers” On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with historic accounting under Topic 605. The Company recorded a net reduction to opening retained earnings of $13.0 million, net of tax, as of January 1, 2018 due to the cumulative impact of adopting Topic 606, with the impact primarily related to the Company’s loyalty point program deferrals. The impact to revenues as a result of applying Topic 606 for the three-month periods ended March 31, 2019, and 2018 was an increase of $0.5 million and an increase of $1.3 million, respectively. Revenue Recognition Net sales include products and shipping and handling charges, net of estimates for product returns and any related sales incentives. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. All revenue is recognized when the Company satisfies the performance obligations under the contract. The Company recognizes revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The Company recognizes revenue for shipping and handling charges at the time the products are delivered to or picked up by the customer. The Company estimates product returns based on historical return rates. The majority of the Company’s contracts have a single performance obligation and are short term in nature. Sales taxes and value added taxes in foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the Condensed Consolidated Balance Sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products on an annual basis. The balance of deferred revenue related to contract liabilities as of $ million and Disaggregation of Revenue Please refer to Note 10 - Segment Information for revenue by segment and product line. Arrangements with Multiple Performance Obligations The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the Company allocates revenues to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged to customers for individual products sales to customers. Practical Expedients and Exemptions The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling expenses. The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less. Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in right-of-use (“ROU”) assets, accrued expenses, and operating lease liabilities on the consolidated balance sheets. The Company has not separately disclosed finance leases, Operating lease ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses their estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company’s lease agreements do not contain any residual value guarantees. The Company has lease agreements with lease and non-lease components. The Company accounts for the lease and non-lease components as a single lease component.

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2019
Goodwill [Abstract]
Goodwill	3. Goodwill During the first quarter of 2019, the Company reorganized the structure of the segments to separately disclose the Manufacturing entities that were acquired in the first quarter of 2018 and the Grow Tech segment, both of which were previously included in the Other category. The Company’s reporting units for goodwill are its operating segments, which are also its reportable segments. The following table presents goodwill allocated to the Company’s reportable segments for the periods ended March 31, 2019 and December 31, 2018 (U.S. dollars in thousands): March 31, 2019 December 31, 2018 Nu Skin Mainland China $ 32,179 $ 32,179 Americas/Pacific 9,449 9,449 South Korea 29,261 29,261 Southeast Asia 18,537 18,537 Japan 16,019 16,019 Hong Kong/Taiwan 6,634 6,634 EMEA 2,875 2,875 Manufacturing 72,469 72,469 Grow Tech 9,150 9,150 Total $ 196,573 $ 196,573

Debt

Debt	3 Months Ended
	Mar. 31, 2019
Debt [Abstract]
Debt	4. Debt Previous Credit Agreement On October 9, 2014, the Company entered into a Credit Agreement (the “Previous Credit Agreement”) with various financial institutions, and Bank of America, N.A. as administrative agent. The Previous Credit Agreement provided for a $127.5 million term loan facility, a 6.6 billion Japanese yen term loan facility and a $187.5 million revolving credit facility, each with a term of five years. On October 10, 2014, the Company drew the full amount of the term loan facilities. On April 18, 2018, the Company repaid the full balance that was outstanding under the Previous Credit Agreement. Existing Credit Agreement On April 18, 2018, the Company entered into a Credit Agreement (the “Existing Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent. The Existing Credit Agreement provides for a $400 million term loan facility and a $350 million revolving credit facility, each with a term of five years. Concurrently with the closing of the Existing Credit Agreement, the Company drew the full amount of the term loan facility and $78.5 million of the revolving facility, each of which initially bear interest at the London Interbank Offered Rate (“LIBOR”), plus 2.25%. The interest rate applicable to the facilities is subject to adjustment based on the Company’s consolidated leverage ratio. The term loan facility will amortize in quarterly installments in amounts resulting in an annual amortization of 5.0% during the first and second years, 7.5% during the third and fourth years and 10.0% during the fifth year after the closing date of the Existing Credit Agreement, with the remainder payable at final maturity. The Existing Credit Agreement requires the Company to maintain a consolidated leverage ratio not exceeding 2.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. Convertible Note On June 16, 2016, the Company issued $210.0 million of convertible senior notes (the “Convertible Notes”) in a private offering to a Chinese investor (the “Holder”). The Convertible Notes were senior unsecured obligations which ranked equal in right of payment to all senior unsecured indebtedness of the Company and ranked senior in right of payment to any indebtedness that was contractually subordinated to the Convertible Notes. Interest on the Convertible Notes was payable semiannually in arrears on June 15 and December 15 of each year at a rate of 4.75% per annum. The Convertible Notes had a stated maturity date of June 15, 2020, unless repurchased or converted prior to maturity. Prior to the stated maturity date, the Company could, at its option, redeem all or part of the Convertible Notes at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, provided that its common stock share price was equal to or exceeded 180% of the applicable conversion price for 20 or more trading days (including the final three trading days) in the 30 consecutive trading days prior to the Company’s exercise of such redemption right. The Holder of the Convertible Notes could, at its option, cause the Company to repurchase all of such Holder’s Convertible Notes or any portion thereof that was equal to $1,000 in principal amount or multiples of $1,000 upon a change in control or a termination of trading of the Company’s common stock, as those terms were defined in the indenture governing the Convertible Notes. In addition, the Holder of the Convertible Notes had the right, at such Holder’s option, to convert all or any portion thereof that is equal to $1,000 in principal amount or multiples of $1,000 at any time beginning six calendar months following June 16, 2016, at the then-applicable conversion rate. Upon conversion by the Holder, the Convertible Notes would be settled in cash with respect to principal and any accrued and unpaid interest to such date and in the Company’s common shares with respect to any additional amounts, based on the applicable conversion rate at such time. The Convertible Notes had an initial conversion rate of 21.5054 common shares per $1,000 principal amount of the Convertible Notes (which is equal to an initial conversion price of approximately $46.50 per common share). Throughout the term of the Convertible Notes, the conversion rate could be adjusted upon the occurrence of certain specified events. Of the $210.0 million in proceeds received from the issuance of the Convertible Notes, $199.1 million was originally allocated to long-term debt (the “Liability Component”) and $10.9 million was allocated to additional paid-in capital (the “Equity Component”) within the Company’s consolidated balance sheet. The Liability Component was calculated by measuring the fair value of a similar debt instrument that does not have an associated conversion feature. The amount allocated to the Equity Component, representing the conversion option, was calculated by deducting the fair value of the Liability Component from the par value of the Convertible Notes. The Company determined that the conversion option did not require separate accounting treatment as a derivative instrument because it was both indexed to the Company’s own stock and would be classified in stockholders’ equity if freestanding. The Equity Component would not be remeasured as long as it continued to meet the conditions for equity classification. The excess of the principal amount of the Liability Component over its carrying amount (the “Debt Discount”) was amortized to interest expense over the term of the Convertible Notes. As a result, the Liability Component was accreted up to the Convertible Notes’ $210.0 million face value, resulting in additional non-cash interest expense being recognized within the Company’s consolidated statement of income. The effective interest rate on the Convertible Notes was approximately 7.1% per annum. The Company incurred approximately $6.6 million of issuance costs related to the issuance of the Convertible Notes. Of the $6.6 million in issuance costs incurred, $6.3 million and $0.3 million were recorded to deferred financing cost and additional paid-in capital, respectively, in proportion to the allocation of the proceeds of the Convertible Notes. The $6.3 million recorded to deferred financing cost on the Company’s consolidated balance sheet as a reduction of long-term debt was amortized over the contractual term of the Convertible Notes using the effective interest method. During the first quarter of 2018 the issuance costs were expensed due to the conversion of the Notes. During the first quarter of 2018, the Holder elected to convert the Convertible Notes pursuant to their terms in the indenture. The Company satisfied the equity portion of its conversion obligation on February 28, 2018 by issuing 1,535,652 shares of the Company’s Class A Common Stock to the Holder and, on April 18, 2018, satisfied and discharged its obligations under the Convertible Notes and the indenture governing the Convertible Notes by paying the Holder $213.4 million which included $3.4 million of accrued interest from December 15, 2017 through April 17, 2018. The early conversion of the notes resulted in a $7.2 million charge to other income (expense) during the first quarter of 2018 for a loss on extinguishment of debt. The following table summarizes the Company’s debt facilities as of March 31, 2019 and December 31, 2018: Facility or Arrangement Original Principal Amount Balance as of March 31, 2019 (1)(2 ) Balance as of December 31, 2018 (2) Interest Rate Repayment Terms April 2018 Credit Agreement term loan facility $ 400.0 million $ 380.0 million $ 385.0 million Variable 30 day: 4.75% 35% of the principal amount is payable in increasing quarterly installments over a five-year period that began on June 30, 2018, with the remainder payable at the end of the five-year term. April 2018 Credit Agreement revolving credit facility $ 25.0 million $ 49.5 million Variable 30 day: 4.82% Revolving line of credit expires April 18, 2023. (1) As of March 31, 2019, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $20.0 million of the balance of its term loan under the Existing Credit Agreement facility. The Company has classified the $25.0 million borrowed under the revolving line of credit as short-term debt because it is the Company’s intention to use the line of credit to borrow and pay back funds over short periods of time. (2) The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $3.8 million as of March 31, 2019 related to the credit agreement.

Leases

Leases	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
Leases	5. Leases The Company has operating and finance leases for regional offices, manufacturing facilities, retail centers, distribution centers and certain equipment. The Company’s leases have remaining lease terms of 1 year to 15 years, some of which include options to extend the leases for up to 10 years, and some of which include options to terminate the leases within 1 year. The Company has not separately disclosed finance leases, The components of lease expense were as follows (U.S. dollars in thousands): Three Months Ended March 31, 2019 Operating lease cost $ 12,861 Short-term lease cost 52 Variable lease cost 1,052 $ 13,965 As of March 31, 2019, the Company had $117.3 million of operating right-of-use assets on the balance sheet, along with $38.9 million and $81.1 million of operating lease liabilities in accrued expenses and long-term operating lease liabilities, respectively. Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Three Months Ended March 31, 2019 Operating cash outflow from operating leases $ 14,377 ROU assets obtained in exchange for lease obligations 128,704 Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31, Operating leases 2019 $ 43,686 2020 33,522 2021 23,544 2022 13,187 2023 8,542 Thereafter 10,398 Total 132,879 Less: Finance charges 12,899 Total principal liability $ 119,980 The Company has additional lease liabilities of $2.6 million which have not yet commenced as of March 31, 2019, and as such, have not been recognized on the Company’s Consolidated balance sheet. Under ASC 840, minimum future operating leases and financing obligations at December 31, 2018 are as follows (U.S. dollars in thousands) : Year Ending December 31, Operating leases Finance leases 2019 $ 39,358 $ 726 2020 27,553 748 2021 20,266 757 2022 11,723 770 2023 9,950 794 Thereafter 7,628 1,148 Total minimum lease payments $ 116,478 $ 4,943

Capital Stock

Capital Stock	3 Months Ended
	Mar. 31, 2019
Capital Stock [Abstract]
Capital Stock	6. Capital Stock Net income per share Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended March 31, 2019 and 2018, stock options of 1.0 million and 0.9 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive. Dividends In February 2019, the Company’s board of directors declared a quarterly cash dividend of $0.37 per share. This quarterly cash dividend of $ 20.5 million was paid on March 13, 2019 to stockholders of record on February 25, 2019. Repurchase of common stock During the three-month periods ended March 31, 2019 and 2018, the Company repurchased approximately 14,000 shares and 0.2 million shares of its Class A common stock under its open market stock repurchase plans for $0.8 million and $17.4 million, respectively. As of March 31, 2019, $470.2 million was available for repurchases under the Company’s open market stock repurchase plan.

Fair Value

Fair Value	3 Months Ended
	Mar. 31, 2019
Fair Value [Abstract]
Fair Value	7. Fair Value The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate fair values due to the short-term nature of these instruments. Fair value estimates are made at a specific point in time, based on relevant market information. The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy: ◾ Level 1 – quoted prices in active markets for identical assets or liabilities; ◾ Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; ◾ Level 3 – unobservable inputs based on the Company’s own assumptions. Accounting standards permit companies, at their option, to measure certain financial instruments and other eligible items at fair value. The Company has elected not to apply the fair value option to existing eligible items beyond what is required by US GAAP. The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at March 31, 2019 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 32,326 $ — $ — $ 32,326 Other long-term assets 3,496 — — 3,496 Life insurance contracts — — 38,516 38,516 Total $ 35,822 $ — $ 38,516 $ 74,338 Fair Value at December 31, 2018 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 35,260 $ — $ — $ 35,260 Other long-term assets 3,568 — — 3,568 Life insurance contracts — — 35,590 35,590 Total $ 38,828 $ — $ 35,590 $ 74,418 The following table provides a summary of changes in fair value of the Company’s Level 3 marketable securities (U.S. dollars in thousands): Beginning balance at January 1, 2019 $ 35,590 Actual return on plan assets 2,441 Purchase and issuances 2,003 Sales and settlements (1,518 ) Transfers into Level 3 — Ending balance at March 31, 2019 $ 38,516

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2019
Income Taxes [Abstract]
Income Taxes	8. Income Taxes Provision for income taxes for the first quarter of 2019 was $22.8 million compared to $24.7 million for the prior-year period. The effective tax rate was 34.7% of pre-tax book income during the first quarter of 2019 compared to 41.0% in the prior-year period. The decrease in the effective tax rate in the first quarter of 2019 is due to additional tax reserves that were booked in first quarter of 2018 related to Indonesia. The Company accounts for income taxes in accordance with the Income Taxes Topic of the Financial Accounting Standards Codification. These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise’s activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. The Company had net deferred tax assets of $19.0 million and net deferred tax liabilities of $5.4 million as of March 31, 2019 and March 31, 2018, respectively. The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter. Other than earnings the Company intends to reinvest indefinitely, the Company accrues for the U.S. federal and state income taxes applicable to the earnings. For all foreign earnings, the Company accrues the applicable foreign income taxes. The Company intends to utilize the offshore earnings to fund foreign investments, specifically capital expenditures. Undistributed earnings that the Company has indefinitely reinvested, for which no federal or state income taxes in the U.S. have been provided, aggregate to $60.0 million as of December 31, 2018. If the amount designated as indefinitely reinvested as of December 31, 2018 was repatriated to the United States, the amount of incremental taxes would be approximately $6.0 million. The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. The Company is no longer subject to tax examinations from the IRS for all years for which tax returns have been filed before 2015. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2015. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process (“CAP”). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. The Company has elected to participate in the CAP program for 2019 and may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. In major foreign jurisdictions, the Company is generally no longer subject to income tax examinations for years before 2012. However, statutes in certain countries may be as long as ten years. The Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable. The Company’s unrecognized tax benefits relate to multiple jurisdictions. Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitation, it is reasonably possible that the Company’s gross unrecognized tax benefits, net of foreign currency adjustments, may increase in the next 12 months by approximately $0.5 to $1.5 million.

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2019
Derivative Financial Instruments [Abstract]
Derivative Financial Instruments	9. Derivative Financial Instruments The Company enters into non-designated foreign currency derivatives, primarily comprised of foreign currency forward contracts, for which hedge accounting does not apply. The changes in the fair market value of these non-designated derivatives are included in other income/expense in the Company’s consolidated statements of income. The Company uses non-designated foreign currency derivatives to hedge foreign-currency-denominated intercompany transactions and to partially mitigate the impact of foreign-currency fluctuations. The fair value of the non-designated foreign currency derivatives is based on third-party quotes. The following table summarizes gains (losses) related to derivative instruments not designated as hedging instruments during the three-month periods ended March 31, 2019 and 2018 (U.S. dollars in thousands): Amount of Gain (Loss) Recognized in Income Derivatives not Designated Location of Gain (Loss) Three Months Ended March 31, as Hedging Instruments: Recognized in Income 2019 2018 Foreign currency contracts Other income (expense) $ — $ — The Company designates as cash-flow hedges those foreign currency forward contracts it enters to hedge forecasted intercompany transactions that are subject to foreign currency exposures. Changes in the fair value of these forward contracts designated as cash-flow hedges are recorded as a component of accumulated other comprehensive loss within shareholders’ equity (deficit) and are recognized in the consolidated statement of income during the period which approximates the time the hedged transaction is settled. As of March 31, 2019, the Company held no forward contracts designated as foreign currency cash flow hedges compared to notional amounts of 0.3 billion Japanese yen ($2.8 million) as of March 31, 2018, to hedge forecasted foreign-currency-denominated intercompany transactions. The fair value of these hedges were zero and $(0.1) million as of March 31, 2019 and 2018, respectively. The following table summarizes gains (losses) related to derivative instruments recorded in other comprehensive income (loss) during the three-month periods ended March 31, 2019 and 2018 (U.S. dollars in thousands): Amount of Gain (Loss) Recognized in Other Comprehensive Loss Derivatives Designated Three Months Ended March 31, as Hedging Instruments: 2019 2018 Foreign currency forward contracts related to intercompany license fee, product sales, and selling expense hedges $ — $ (247 ) The following table summarizes gains (losses) relating to derivative instruments reclassified from accumulated other comprehensive loss into income during the three-month periods ended March 31, 2019 and 2018 (U.S. dollars in thousands): Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Derivatives Designated Location of Gain (Loss) Reclassified from Accumulated Three Months Ended March 31, as Hedging Instruments: Other Comprehensive Loss into Income 2019 2018 Foreign currency forward contracts related to intercompany license fees and product sales hedges Revenue $ — $ (49 ) Foreign currency forward contracts related to intercompany selling expense hedges Selling expenses $ — $ — As of March 31, 2019 and December 31, 2018, there were no unrealized gains/(losses) included in accumulated other comprehensive loss related to foreign currency cash flow hedges. The remaining $75.8 million and $79.9 million as of March 31, 2019 and December 31, 2018, respectively, in accumulated other comprehensive loss are related to cumulative translation adjustments. The Company assesses hedge effectiveness at least quarterly. During the three-months period ended March 31, 2018, all hedges were determined to be effective. The Company reports its derivatives at fair value as either other current assets or accrued expenses within its consolidated balance sheet. See Note 7 - Fair Value.

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2019
Segment Information [Abstract]
Segment Information	10. Segment Information The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments—Mainland China, South Korea, Southeast Asia, Americas/Pacific, Japan, Hong Kong/Taiwan, and Europe, Middle East and Africa (“EMEA”)—and its Manufacturing and Grow Tech segments, which the Company has decided to disclose separately beginning in the first quarter of 2019. Previously, these latter two segments were included in the Other category. The Other category includes miscellaneous corporate revenue and related adjustments. These segments reflect the way the chief operating decision maker evaluates the Company’s business performance and allocates resources. Reported revenue includes only the revenue generated by sales to external customers. Segment information for the three-month period ended March 31, 2018 has been recast to reflect the separate disclosure of the Manufacturing and Grow Tech segments, both of which were previously included in the Other category. Consolidated financial information is not affected. Profitability by segment as determined under US GAAP is driven primarily by the Company’s transfer pricing policies. Segment contribution, which is the Company’s segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company’s executive and administrative offices, information technology, research and development, and marketing and supply chain functions not recorded at the segment level. The accounting policies of the segments are the same as those described in Note 1 – The Company. The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations. Summarized financial information for the Company’s reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company’s internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment. Revenue by Segment Three Months Ended March 31, (U.S. dollars in thousands) 2019 2018 Nu Skin Mainland China $ 208,488 $ 197,531 Americas/Pacific 86,456 92,289 South Korea 83,853 88,930 Southeast Asia 72,495 70,860 Japan 62,109 63,224 Hong Kong/Taiwan 40,558 40,992 EMEA 41,818 44,981 Other (1,426 ) 235 Total Nu Skin 594,351 599,042 Manufacturing (1) 29,272 17,177 Grow Tech — — Total $ 623,623 $ 616,219 (1) The Manufacturing segment had $5.9 million and $3.2 million of intersegment revenue for the three-month period ended March 31, 2019 and 2018, respectively. Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above. Segment Contribution Three Months Ended March 31, (U.S. dollars in thousands) 2019 2018 Nu Skin Mainland China $ 59,167 $ 44,817 Americas/Pacific 12,019 9,172 South Korea 25,668 26,201 Southeast Asia 17,992 16,402 Japan 14,106 13,238 Hong Kong/Taiwan 7,474 7,846 EMEA 1,351 4,754 Nu Skin contribution 137,777 122,430 Manufacturing 3,646 (354 ) Grow Tech (3,629 ) (1,260 ) Total segment contribution 137,794 120,816 Corporate and other (69,141 ) (61,826 ) Operating income 68,653 58,990 Other income (expense) (2,848 ) 1,207 Income before provision for income taxes $ 65,805 $ 60,197 Depreciation and Amortization Three Months Ended March 31, (U.S. dollars in thousands) 2019 2018 Nu Skin Mainland China $ 3,116 $ 3,487 Americas/Pacific 214 214 South Korea 1,524 1,667 Southeast Asia 477 559 Japan 1,048 915 Hong Kong/Taiwan 516 323 EMEA 440 176 Total Nu Skin 7,335 7,341 Manufacturing 1,574 2,825 Grow Tech 875 218 Corporate and other 9,823 8,523 Total $ 19,607 $ 18,907 Capital Expenditures Three Months Ended March 31, (U.S. dollars in thousands) 2019 2018 Nu Skin Mainland China $ 1,681 $ 1,869 Americas/Pacific 274 189 South Korea 49 — Southeast Asia 94 51 Japan 172 311 Hong Kong/Taiwan 463 482 EMEA 34 35 Total Nu Skin 2,767 2,937 Manufacturing 1,602 749 Grow Tech 2,985 2,587 Corporate and other 6,411 6,379 Total $ 13,765 $ 12,652

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2019
Commitments and Contingencies [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company’s direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company’s sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company’s operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. No assurance can be given that the Company’s compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company’s financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation, investigations and other proceedings involving various matters. In the opinion of the Company’s management, based on management’s evaluation of the matters and the advice of its counsel handling such litigation, investigations and other proceedings, adverse outcomes, if any, are not currently expected to result in a material effect on the Company’s consolidated financial condition, results of operations or cash flows. The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company’s reserves, which would impact its reported financial results.

Acquisitions

Acquisitions	3 Months Ended
	Mar. 31, 2019
Acquisitions [Abstract]
Acquisitions	12. Acquisitions On January 22, 2018, the Company acquired the remaining 73% ownership in Innuvate Health Sciences, LLC (“Innuvate”), which owns a 92% interest in a nutritional product manufacturer. Prior to this acquisition, the Company owned 27% of Innuvate and accounted for it using the equity method. The remaining 8% ownership in the manufacturer will continue to be held by an unrelated third party. Under the terms of the agreement, the Company paid $23.5 million in cash and shares of the Company in exchange for the 73% ownership in Innuvate. Innuvate is a contract manufacturer that specializes in softgel and hardshell capsule manufacturing. On February 12, 2018, the Company acquired the remaining 65% ownership in Treviso, LLC (“Treviso”), making Treviso a wholly owned subsidiary of the Company. Treviso is a personal care product manufacturer. Prior to this acquisition, the Company owned 35% of Treviso and accounted for it using the equity method. Under the terms of the purchase agreement, the Company has paid $83.9 million in cash and shares of the Company in exchange for the 65% ownership in Treviso. Treviso is a liquid contract manufacturing laboratory for premium personal care products. On February 12, 2018, the Company acquired 100% ownership in L&W Holdings, Inc. (“L&W”) making L&W a wholly owned subsidiary of the Company. L&W is a packaging supplier company. Under the terms of the purchase agreement, the Company paid $25.0 million in shares of the Company in exchange for 100% ownership in L&W. L&W specializes in the distribution and packaging of products in the cosmetic and nutritional industries. The following table summarizes the fair value of consideration transferred for the acquisitions disclosed above (in thousands): Innuvate Treviso L&W Holdings Total Total cash consideration $ 17,587 $ 14,648 $ — $ 32,235 Shares issued in conjunction with acquisition 5,863 69,252 25,000 100,115 Total consideration $ 23,450 $ 83,900 $ 25,000 132,350 Previously held equity interest in equity method Investments (1) 8,748 30,281 — 39,029 Total $ 32,198 $ 114,181 $ 25,000 $ 171,379 (1) The acquisitions of Innuvate and Treviso are considered step acquisitions, and accordingly, the Company remeasured its pre-existing 27% equity interest in Innuvate and 35% of Treviso immediately prior to completion of the acquisition to its estimated fair value of approximately $39.0 million. As a result of the remeasurement, the Company recorded a gain of approximately $13.6 million within other income (expense), during the first quarter of 2018, representing the excess of the approximate $39.0 million estimated fair value of its pre-existing 27% equity interest in Innuvate and 35% equity interest of Treviso over its transaction date carrying value of approximately $25.4 million. The following table summarizes the fair value of the assets acquired for the acquisitions disclosed above (in thousands): Innuvate Treviso L&W Holdings Life Amount Life Amount Life Amount Total current assets $ 6,219 $ 19,659 $ 7,353 Fixed assets 9,291 33,282 114 Customer list 9 years 5,100 9 years 16,500 7 years 6,500 Order backlog 5 months 200 10 months 4,700 4 months 900 Trademarks 7 years 900 6 years 1,300 5 years 600 Total current liabilities (3,942 ) (3,740 ) (1,495 ) Other non-current liabilities — — (1,731 ) Total identifiable net assets acquired 17,768 71,701 12,241 Goodwill 17,230 42,480 12,759 Fair value of noncontrolling interest (2,800 ) — — Total consideration and value to be allocated to net assets $ 32,198 $ 114,181 $ 25,000 Pro forma and historical results of operations for the acquired companies have not been presented because they are not material, either individually or in the aggregate, to the company’s consolidated financial statements.

Restructuring

Restructuring	3 Months Ended
	Mar. 31, 2019
Restructuring [Abstract]
Restructuring	13. Restructuring In the fourth quarter of 2018, the Company began a strategic plan to align its resources and capabilities to support its vision of being a world-leading business platform. This program primarily impacted the Company’s information technology infrastructure and organization and other departments within its corporate and Americas offices. As a result of the restructuring program, the Company recorded a non-cash charge of $48.6 million for impairment of information technology assets, including internally developed software for social sharing and digital initiatives, and $22.1 million of cash charges, including $20.1 million for employee severance and $2.0 million for other related cash charges with the restructuring. The restructuring charges were predominately recorded in the Corporate and Other category. See table below for detail of restructuring activity for the three months ended March 31, 2019 (U.S. dollars in thousands): Beginning balance at January 1, 2019 $ 15,462 Amounts paid (15,046 ) Adjustments (416 ) Ending balance at March 31, 2019 $ —

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2019
Summary of Significant Accounting Policies [Abstract]
Accounting Pronouncements	Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) In February 2016, the FASB issued ASU 2016-02, Leases In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This guidance simplifies the required test of goodwill for impairment by eliminating Step 2 from the goodwill impairment test. If a company determines in Step 1 of the goodwill impairment test that the carrying value of a reporting unit is less than the fair value, an impairment in that amount should be recorded to the income statement, rather than proceeding to Step 2. This ASU is effective for interim and annual impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted. The Company has elected to early adopt the new standard effective January 1, 2019. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. In December 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities This ASU was effective for the Company beginning on January 1, 2019. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. In February 2018, the FASB issued ASU 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The Company has elected to early adopt the standard effective October 1, 2018. The cumulative impact of adoption was a $1.7 million net reduction to beginning retained earnings. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.
Inventory	Inventory Inventories consist of the following (U.S. dollars in thousands): March 31, 2019 December 31, 2018 Raw materials $ 89,984 $ 91,610 Finished goods 214,327 204,211 Total Inventory, net $ 304,311 $ 295,821
Revenue Recognition	Revenue Recognition Adoption of ASC Topic 606, “Revenue from Contracts with Customers” On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with historic accounting under Topic 605. The Company recorded a net reduction to opening retained earnings of $13.0 million, net of tax, as of January 1, 2018 due to the cumulative impact of adopting Topic 606, with the impact primarily related to the Company’s loyalty point program deferrals. The impact to revenues as a result of applying Topic 606 for the three-month periods ended March 31, 2019, and 2018 was an increase of $0.5 million and an increase of $1.3 million, respectively. Revenue Recognition Net sales include products and shipping and handling charges, net of estimates for product returns and any related sales incentives. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. All revenue is recognized when the Company satisfies the performance obligations under the contract. The Company recognizes revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The Company recognizes revenue for shipping and handling charges at the time the products are delivered to or picked up by the customer. The Company estimates product returns based on historical return rates. The majority of the Company’s contracts have a single performance obligation and are short term in nature. Sales taxes and value added taxes in foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the Condensed Consolidated Balance Sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products on an annual basis. The balance of deferred revenue related to contract liabilities as of $ million and Disaggregation of Revenue Please refer to Note 10 - Segment Information for revenue by segment and product line. Arrangements with Multiple Performance Obligations The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the Company allocates revenues to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged to customers for individual products sales to customers. Practical Expedients and Exemptions The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling expenses. The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.
Leases	Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in right-of-use (“ROU”) assets, accrued expenses, and operating lease liabilities on the consolidated balance sheets. The Company has not separately disclosed finance leases, Operating lease ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses their estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company’s lease agreements do not contain any residual value guarantees. The Company has lease agreements with lease and non-lease components. The Company accounts for the lease and non-lease components as a single lease component.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2019
Summary of Significant Accounting Policies [Abstract]
Inventories	Inventories consist of the following (U.S. dollars in thousands): March 31, 2019 December 31, 2018 Raw materials $ 89,984 $ 91,610 Finished goods 214,327 204,211 Total Inventory, net $ 304,311 $ 295,821

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2019
Goodwill [Abstract]
Goodwill	The following table presents goodwill allocated to the Company’s reportable segments for the periods ended March 31, 2019 and December 31, 2018 (U.S. dollars in thousands): March 31, 2019 December 31, 2018 Nu Skin Mainland China $ 32,179 $ 32,179 Americas/Pacific 9,449 9,449 South Korea 29,261 29,261 Southeast Asia 18,537 18,537 Japan 16,019 16,019 Hong Kong/Taiwan 6,634 6,634 EMEA 2,875 2,875 Manufacturing 72,469 72,469 Grow Tech 9,150 9,150 Total $ 196,573 $ 196,573

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2019
Debt [Abstract]
Debt Facilities	The following table summarizes the Company’s debt facilities as of March 31, 2019 and December 31, 2018: Facility or Arrangement Original Principal Amount Balance as of March 31, 2019 (1)(2 ) Balance as of December 31, 2018 (2) Interest Rate Repayment Terms April 2018 Credit Agreement term loan facility $ 400.0 million $ 380.0 million $ 385.0 million Variable 30 day: 4.75% 35% of the principal amount is payable in increasing quarterly installments over a five-year period that began on June 30, 2018, with the remainder payable at the end of the five-year term. April 2018 Credit Agreement revolving credit facility $ 25.0 million $ 49.5 million Variable 30 day: 4.82% Revolving line of credit expires April 18, 2023. (1) As of March 31, 2019, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $20.0 million of the balance of its term loan under the Existing Credit Agreement facility. The Company has classified the $25.0 million borrowed under the revolving line of credit as short-term debt because it is the Company’s intention to use the line of credit to borrow and pay back funds over short periods of time. (2) The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $3.8 million as of March 31, 2019 related to the credit agreement.

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
Components of Lease Expense	The components of lease expense were as follows (U.S. dollars in thousands): Three Months Ended March 31, 2019 Operating lease cost $ 12,861 Short-term lease cost 52 Variable lease cost 1,052 $ 13,965
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Three Months Ended March 31, 2019 Operating cash outflow from operating leases $ 14,377 ROU assets obtained in exchange for lease obligations 128,704
Maturities of Operating Lease Liabilities	Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31, Operating leases 2019 $ 43,686 2020 33,522 2021 23,544 2022 13,187 2023 8,542 Thereafter 10,398 Total 132,879 Less: Finance charges 12,899 Total principal liability $ 119,980
Minimum Future Operating Leases and Financing Obligations	Under ASC 840, minimum future operating leases and financing obligations at December 31, 2018 are as follows (U.S. dollars in thousands) : Year Ending December 31, Operating leases Finance leases 2019 $ 39,358 $ 726 2020 27,553 748 2021 20,266 757 2022 11,723 770 2023 9,950 794 Thereafter 7,628 1,148 Total minimum lease payments $ 116,478 $ 4,943

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Mar. 31, 2019
Fair Value [Abstract]
Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at March 31, 2019 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 32,326 $ — $ — $ 32,326 Other long-term assets 3,496 — — 3,496 Life insurance contracts — — 38,516 38,516 Total $ 35,822 $ — $ 38,516 $ 74,338 Fair Value at December 31, 2018 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 35,260 $ — $ — $ 35,260 Other long-term assets 3,568 — — 3,568 Life insurance contracts — — 35,590 35,590 Total $ 38,828 $ — $ 35,590 $ 74,418
Changes in Fair Value of Level 3 Marketable Securities	The following table provides a summary of changes in fair value of the Company’s Level 3 marketable securities (U.S. dollars in thousands): Beginning balance at January 1, 2019 $ 35,590 Actual return on plan assets 2,441 Purchase and issuances 2,003 Sales and settlements (1,518 ) Transfers into Level 3 — Ending balance at March 31, 2019 $ 38,516

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2019
Derivative Financial Instruments [Abstract]
Gains (Losses) Related to Derivative Instruments Not Designated as Hedging Instruments	The following table summarizes gains (losses) related to derivative instruments not designated as hedging instruments during the three-month periods ended March 31, 2019 and 2018 (U.S. dollars in thousands): Amount of Gain (Loss) Recognized in Income Derivatives not Designated Location of Gain (Loss) Three Months Ended March 31, as Hedging Instruments: Recognized in Income 2019 2018 Foreign currency contracts Other income (expense) $ — $ —
Gains (Losses) Related to Derivative Instruments Designated as Cash Flow Hedges	The following table summarizes gains (losses) related to derivative instruments recorded in other comprehensive income (loss) during the three-month periods ended March 31, 2019 and 2018 (U.S. dollars in thousands): Amount of Gain (Loss) Recognized in Other Comprehensive Loss Derivatives Designated Three Months Ended March 31, as Hedging Instruments: 2019 2018 Foreign currency forward contracts related to intercompany license fee, product sales, and selling expense hedges $ — $ (247 ) The following table summarizes gains (losses) relating to derivative instruments reclassified from accumulated other comprehensive loss into income during the three-month periods ended March 31, 2019 and 2018 (U.S. dollars in thousands): Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Derivatives Designated Location of Gain (Loss) Reclassified from Accumulated Three Months Ended March 31, as Hedging Instruments: Other Comprehensive Loss into Income 2019 2018 Foreign currency forward contracts related to intercompany license fees and product sales hedges Revenue $ — $ (49 ) Foreign currency forward contracts related to intercompany selling expense hedges Selling expenses $ — $ —

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2019
Segment Information [Abstract]
Revenue by Segment	Revenue by Segment Three Months Ended March 31, (U.S. dollars in thousands) 2019 2018 Nu Skin Mainland China $ 208,488 $ 197,531 Americas/Pacific 86,456 92,289 South Korea 83,853 88,930 Southeast Asia 72,495 70,860 Japan 62,109 63,224 Hong Kong/Taiwan 40,558 40,992 EMEA 41,818 44,981 Other (1,426 ) 235 Total Nu Skin 594,351 599,042 Manufacturing (1) 29,272 17,177 Grow Tech — — Total $ 623,623 $ 616,219 (1) The Manufacturing segment had $5.9 million and $3.2 million of intersegment revenue for the three-month period ended March 31, 2019 and 2018, respectively. Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above.
Segment Contribution	Segment Contribution Three Months Ended March 31, (U.S. dollars in thousands) 2019 2018 Nu Skin Mainland China $ 59,167 $ 44,817 Americas/Pacific 12,019 9,172 South Korea 25,668 26,201 Southeast Asia 17,992 16,402 Japan 14,106 13,238 Hong Kong/Taiwan 7,474 7,846 EMEA 1,351 4,754 Nu Skin contribution 137,777 122,430 Manufacturing 3,646 (354 ) Grow Tech (3,629 ) (1,260 ) Total segment contribution 137,794 120,816 Corporate and other (69,141 ) (61,826 ) Operating income 68,653 58,990 Other income (expense) (2,848 ) 1,207 Income before provision for income taxes $ 65,805 $ 60,197
Depreciation and Amortization and Capital Expenditures	Depreciation and Amortization Three Months Ended March 31, (U.S. dollars in thousands) 2019 2018 Nu Skin Mainland China $ 3,116 $ 3,487 Americas/Pacific 214 214 South Korea 1,524 1,667 Southeast Asia 477 559 Japan 1,048 915 Hong Kong/Taiwan 516 323 EMEA 440 176 Total Nu Skin 7,335 7,341 Manufacturing 1,574 2,825 Grow Tech 875 218 Corporate and other 9,823 8,523 Total $ 19,607 $ 18,907 Capital Expenditures Three Months Ended March 31, (U.S. dollars in thousands) 2019 2018 Nu Skin Mainland China $ 1,681 $ 1,869 Americas/Pacific 274 189 South Korea 49 — Southeast Asia 94 51 Japan 172 311 Hong Kong/Taiwan 463 482 EMEA 34 35 Total Nu Skin 2,767 2,937 Manufacturing 1,602 749 Grow Tech 2,985 2,587 Corporate and other 6,411 6,379 Total $ 13,765 $ 12,652

Acquisitions (Tables)

Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2019
Acquisitions [Abstract]
Acquisitions	The following table summarizes the fair value of consideration transferred for the acquisitions disclosed above (in thousands): Innuvate Treviso L&W Holdings Total Total cash consideration $ 17,587 $ 14,648 $ — $ 32,235 Shares issued in conjunction with acquisition 5,863 69,252 25,000 100,115 Total consideration $ 23,450 $ 83,900 $ 25,000 132,350 Previously held equity interest in equity method Investments (1) 8,748 30,281 — 39,029 Total $ 32,198 $ 114,181 $ 25,000 $ 171,379 (1) The acquisitions of Innuvate and Treviso are considered step acquisitions, and accordingly, the Company remeasured its pre-existing 27% equity interest in Innuvate and 35% of Treviso immediately prior to completion of the acquisition to its estimated fair value of approximately $39.0 million. As a result of the remeasurement, the Company recorded a gain of approximately $13.6 million within other income (expense), during the first quarter of 2018, representing the excess of the approximate $39.0 million estimated fair value of its pre-existing 27% equity interest in Innuvate and 35% equity interest of Treviso over its transaction date carrying value of approximately $25.4 million. The following table summarizes the fair value of the assets acquired for the acquisitions disclosed above (in thousands): Innuvate Treviso L&W Holdings Life Amount Life Amount Life Amount Total current assets $ 6,219 $ 19,659 $ 7,353 Fixed assets 9,291 33,282 114 Customer list 9 years 5,100 9 years 16,500 7 years 6,500 Order backlog 5 months 200 10 months 4,700 4 months 900 Trademarks 7 years 900 6 years 1,300 5 years 600 Total current liabilities (3,942 ) (3,740 ) (1,495 ) Other non-current liabilities — — (1,731 ) Total identifiable net assets acquired 17,768 71,701 12,241 Goodwill 17,230 42,480 12,759 Fair value of noncontrolling interest (2,800 ) — — Total consideration and value to be allocated to net assets $ 32,198 $ 114,181 $ 25,000

Restructuring (Tables)

Restructuring (Tables)	3 Months Ended
	Mar. 31, 2019
Restructuring [Abstract]
Restructuring Activity	See table below for detail of restructuring activity for the three months ended March 31, 2019 (U.S. dollars in thousands): Beginning balance at January 1, 2019 $ 15,462 Amounts paid (15,046 ) Adjustments (416 ) Ending balance at March 31, 2019 $ —

The Company (Details)

The Company (Details)	3 Months Ended
	Mar. 31, 2019Segment
The Company [Abstract]
Number of reportable segments	9
Number of geographic segments	7

Summary of Significant Accoun_4

Summary of Significant Accounting Policies, Accounting Pronouncements (Details) - USD ($) $ in Millions	Dec. 31, 2018	Sep. 30, 2018	Dec. 31, 2017
ASU 2014-09 [Member]
Accounting Pronouncements [Abstract]
Cumulative impact on opening retained earnings			$ 13
ASU 2016-02 [Member]
Accounting Pronouncements [Abstract]
Cumulative impact on opening retained earnings	$ 0.7
ASU 2018-02 [Member]
Accounting Pronouncements [Abstract]
Cumulative impact on opening retained earnings		$ 1.7

Summary of Significant Accoun_5

Summary of Significant Accounting Policies, Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Inventories [Abstract]
Raw materials	$ 89,984	$ 91,610
Finished goods	214,327	204,211
Total Inventory, net	$ 304,311	$ 295,821

Summary of Significant Accoun_6

Summary of Significant Accounting Policies, Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2017
Revenue Recognition [Abstract]
Revenue	$ 623,623	$ 616,219
ASC Topic 606 [Member]
Revenue Recognition [Abstract]
Cumulative impact on opening retained earnings			$ 13,000
Impact of Adopting ASC Topic 606 [Member] | ASC Topic 606 [Member]
Revenue Recognition [Abstract]
Revenue	$ 500	$ 1,300

Summary of Significant Accoun_7

Summary of Significant Accounting Policies, Contract Liabilities - Customer Loyalty Programs (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs	$ 13.3	$ 13.8

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Goodwill [Abstract]
Goodwill	$ 196,573	$ 196,573
Manufacturing [Member]
Goodwill [Abstract]
Goodwill	72,469	72,469
Grow Tech [Member]
Goodwill [Abstract]
Goodwill	9,150	9,150
Mainland China [Member]
Goodwill [Abstract]
Goodwill	32,179	32,179
Americas/Pacific [Member]
Goodwill [Abstract]
Goodwill	9,449	9,449
South Korea [Member]
Goodwill [Abstract]
Goodwill	29,261	29,261
Southeast Asia [Member]
Goodwill [Abstract]
Goodwill	18,537	18,537
Japan [Member]
Goodwill [Abstract]
Goodwill	16,019	16,019
Hong Kong/Taiwan [Member]
Goodwill [Abstract]
Goodwill	6,634	6,634
EMEA [Member]
Goodwill [Abstract]
Goodwill	$ 2,875	$ 2,875

Debt, Previous Credit Agreement

Debt, Previous Credit Agreement (Details) $ in Millions, ¥ in Billions	3 Months Ended
	Mar. 31, 2019	Oct. 09, 2014USD ($)	Oct. 09, 2014JPY (¥)
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount		$ 127.5
Term of loan	5 years
Japanese Yen Term Loan Facility [Member]
Debt [Abstract]
Original principal amount | ¥			¥ 6.6
Term of loan	5 years
Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity		$ 187.5
Term of loan	5 years

Debt, Existing Credit Agreement

Debt, Existing Credit Agreement (Details) - USD ($) $ in Thousands	Apr. 18, 2018	Mar. 31, 2019	Mar. 31, 2018
Debt [Abstract]
Proceeds from debt		$ 105,000	$ 75,943
Existing Credit Agreement [Member] | Maximum [Member]
Debt [Abstract]
Consolidated leverage ratio		2.25
Existing Credit Agreement [Member] | Minimum [Member]
Debt [Abstract]
Consolidated interest coverage ratio		3
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 400,000	$ 400,000
Term of loan		5 years
Term Loan Facility [Member] | First Year [Member]
Debt [Abstract]
Annual amortization percentage		5.00%
Term Loan Facility [Member] | Second Year [Member]
Debt [Abstract]
Annual amortization percentage		5.00%
Term Loan Facility [Member] | Third Year [Member]
Debt [Abstract]
Annual amortization percentage		7.50%
Term Loan Facility [Member] | Fourth Year [Member]
Debt [Abstract]
Annual amortization percentage		7.50%
Term Loan Facility [Member] | Fifth Year [Member]
Debt [Abstract]
Annual amortization percentage		10.00%
Term Loan Facility [Member] | LIBOR [Member]
Debt [Abstract]
Basis spread on variable rate		2.25%
Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity	350,000
Term of loan		5 years
Proceeds from debt	$ 78,500
Revolving Credit Facility [Member] | LIBOR [Member]
Debt [Abstract]
Basis spread on variable rate		2.25%

Debt, Convertible Note (Details

Debt, Convertible Note (Details)	Apr. 18, 2018USD ($)	Feb. 28, 2018shares	Jun. 16, 2016USD ($)	Mar. 31, 2019USD ($)d$ / sharesshares	Mar. 31, 2018USD ($)	Apr. 17, 2018USD ($)
Convertible Debt [Abstract]
Loss on extinguishment of debt				$ 0	$ (7,220,000)
Class A Common Stock [Member]
Convertible Debt [Abstract]
Shares issued (in shares) | shares		1,535,652
Convertible Note [Member]
Convertible Debt [Abstract]
Original principal amount			$ 210,000,000
Interest rate				4.75%
Maturity date				Jun. 15, 2020
Redemption price, percentage of principal amount redeemed				100.00%
Threshold percentage of stock price trigger				180.00%
Threshold trading days | d				20
Threshold final trading days | d				3
Threshold consecutive trading days | d				30
Principal amount increments that can be repurchased upon a change in control or termination of trading of common stock				$ 1,000
Principal amount increments that can be converted				$ 1,000
Holding period following issue date before notes can be converted				6 months
Initial conversion rate (in shares) | shares				21.5054
Initial conversion price (in dollars per share) | $ / shares				$ 46.50
Proceeds from issuance of notes			210,000,000
Liability component of convertible notes			199,100,000
Equity component of convertible notes allocated to additional paid-in capital			$ 10,900,000
Effective interest rate				7.10%
Debt issuance costs				$ 6,600,000
Additions to deferred financing cost				6,300,000
Adjustments to additional paid-in capital for debt issuance costs				$ 300,000
Payment for principal and accrued interest	$ 213,400,000
Accrued interest						$ 3,400,000
Loss on extinguishment of debt					$ (7,220,000)

Debt, Debt Facilities (Details)

Debt, Debt Facilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019		Dec. 31, 2018	Apr. 18, 2018
Debt [Abstract]
Current portion of long-term debt	$ 45,000		$ 69,455
April 2018 Credit Agreement [Member]
Debt [Abstract]
Unamortized debt issuance costs	3,800
April 2018 Credit Agreement Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	400,000			$ 400,000
Balance	$ 380,000	[1],[2]	385,000
Interest rate	Variable 30 day: 4.75%
Interest rate	4.75%
Term of variable rate	30 days
Repayment terms	35% of the principal amount is payable in increasing quarterly installments over a five-year period that began on June 30, 2018, with the remainder payable at the end of the five-year term.
Percentage of principal payable in installments	35.00%
Term of loan	5 years
Current portion of long-term debt	$ 20,000
April 2018 Credit Agreement Revolving Credit Facility [Member]
Debt [Abstract]
Balance	$ 25,000	[1],[2]	$ 49,500
Interest rate	Variable 30 day: 4.82%
Interest rate	4.82%
Term of variable rate	30 days
Repayment terms	Revolving line of credit expires April 18, 2023.
Term of loan	5 years
Current portion of long-term debt	$ 25,000
[1]	As of March 31, 2019, the current portion of the Company's debt (i.e. becoming due in the next 12 months) included $20.0 million of the balance of its term loan under the Existing Credit Agreement facility. The Company has classified the $25.0 million borrowed under the revolving line of credit as short-term debt because it is the Company's intention to use the line of credit to borrow and pay back funds over short periods of time.
[2]	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $3.8 million as of March 31, 2019 related to the credit agreement.

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Leases [Abstract]
Weighted average remaining lease term for operating leases	4 years 1 month 6 days
Weighted average discount rate for operating leases	4.80%
Components of Lease Expense [Abstract]
Operating lease cost	$ 12,861
Short-term lease cost	52
Variable lease cost	1,052
Total lease expense	13,965
Operating right-of-use assets	117,329	$ 0
Current operating lease liabilities	38,900
Long-term operating lease liabilities	81,075	0
Supplemental Cash Flow Information Related to Leases [Abstract]
Operating cash outflow from operating leases	14,377
ROU assets obtained in exchange for lease obligations	128,704
Maturities of Operating Lease Liabilities [Abstract]
2019	43,686
2020	33,522
2021	23,544
2022	13,187
2023	8,542
Thereafter	10,398
Total	132,879
Less: Finance charges	12,899
Total principal liability	119,980
Additional lease liabilities not yet commenced	$ 2,600
Operating Leases, Minimum Future Obligations [Abstract]
2019		39,358
2020		27,553
2021		20,266
2022		11,723
2023		9,950
Thereafter		7,628
Total minimum lease payments		116,478
Financing Obligations, Minimum Future Obligations [Abstract]
2019		726
2020		748
2021		757
2022		770
2023		794
Thereafter		1,148
Total minimum lease payments		$ 4,943
Minimum [Member]
Leases [Abstract]
Remaining lease terms	1 year
Maximum [Member]
Leases [Abstract]
Remaining lease terms	15 years
Extension period for leases	10 years
Termination period for leases	1 year

Capital Stock (Details)

Capital Stock (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	Mar. 13, 2019	Apr. 30, 2019	Feb. 28, 2018	Mar. 31, 2019	Mar. 31, 2018
Dividends per Share [Abstract]
Payment of cash dividends				$ 20,531	$ 19,801
Repurchases of Common Stock [Abstract]
Class A common stock repurchased				825	$ 17,386
Amount available for repurchases				$ 470,200
Treasury Stock [Member]
Repurchases of Common Stock [Abstract]
Class A common stock repurchased (in shares)				14	200
Class A common stock repurchased				$ 825	$ 17,386
Dividend Declared 2019 Q1 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared				2019-02
Dividend payable per share (in dollars per share)			$ 0.37
Payment of cash dividends	$ 20,500
Dividend payable, date paid				Mar. 13, 2019
Dividend payable, date of record				Feb. 25, 2019
Dividend Declared 2019 Q2 [Member] | Subsequent Event [Member]
Dividends per Share [Abstract]
Dividend payable, date declared		2019-04
Dividend payable per share (in dollars per share)		$ 0.37
Dividend payable, date paid		Jun. 12, 2019
Dividend payable, date of record		May 31, 2019
Stock Options [Member]
Net Income per Share [Abstract]
Anti-dilutive shares excluded from calculation of diluted earnings per share (in shares)				1,000	900

Fair Value (Details)

Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Fair Value on a Recurring Basis [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	$ 32,326	$ 35,260
Other long-term assets	3,496	3,568
Life insurance contracts	38,516	35,590
Financial assets (liabilities), net	74,338	74,418
Fair Value on a Recurring Basis [Member] | Level 1 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	32,326	35,260
Other long-term assets	3,496	3,568
Life insurance contracts	0	0
Financial assets (liabilities), net	35,822	38,828
Fair Value on a Recurring Basis [Member] | Level 2 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Other long-term assets	0	0
Life insurance contracts	0	0
Financial assets (liabilities), net	0	0
Fair Value on a Recurring Basis [Member] | Level 3 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Other long-term assets	0	0
Life insurance contracts	38,516	35,590
Financial assets (liabilities), net	38,516	$ 35,590
Life Insurance Contracts [Member]
Changes in Fair Value of Level 3 Marketable Securities [Roll Forward]
Beginning balance	35,590
Actual return on plan assets	2,441
Purchases and issuances	2,003
Sales and settlements	(1,518)
Transfers into Level 3	0
Ending balance	$ 38,516

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Income Taxes [Abstract]
Provision for income taxes	$ 22,803	$ 24,658
Effective tax rate	34.70%	41.00%
Net deferred tax assets	$ 19,000
Net deferred tax liabilities		$ 5,400
Undistributed earnings of non-U.S. subsidiaries			$ 60,000
Incremental taxes if undistributed earnings on non-U.S. subsidiaries were repatriated			$ 6,000
Minimum [Member]
Income Taxes [Abstract]
Decrease in unrecognized tax benefits within the next 12 months that is reasonably possible	$ 500
Maximum [Member]
Income Taxes [Abstract]
Statute of limitations related to income tax examinations	10 years
Income Taxes [Abstract]
Decrease in unrecognized tax benefits within the next 12 months that is reasonably possible	$ 1,500

Derivative Financial Instrume_3

Derivative Financial Instruments (Details) $ in Thousands, ¥ in Billions	3 Months Ended
	Mar. 31, 2019USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2018USD ($)	Mar. 31, 2018JPY (¥)
Foreign Currency Derivatives [Abstract]
Unrealized gains/(losses) related to foreign currency cash flow hedges included in accumulated other comprehensive loss	$ 0		$ 0
Cumulative translation adjustments included in accumulated other comprehensive loss	75,800		$ 79,900
Foreign Currency Forward Contracts [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Notional amount	0
Fair value	0	$ 100
Foreign Currency Forward Contracts [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedges [Member] | Japanese Yen [Member]
Foreign Currency Derivatives [Abstract]
Notional amount		2,800		¥ 0.3
Foreign Currency Forward Contracts [Member] | Other Comprehensive Income (Loss) [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) recognized in other comprehensive loss	0	(247)
Foreign Currency Forward Contracts [Member] | Other Income (Expense) [Member] | Not Designated as Hedging Instrument [Member] | Fair Value Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) recognized in income	0	0
Foreign Currency Forward Contracts [Member] | Revenue [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	0	(49)
Foreign Currency Forward Contracts [Member] | Selling Expenses [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedges [Member]
Foreign Currency Derivatives [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	$ 0	$ 0

Segment Information, Revenue by

Segment Information, Revenue by Segment (Details) $ in Thousands		3 Months Ended
		Mar. 31, 2019USD ($)Segment	Mar. 31, 2018USD ($)
Segment Information [Abstract]
Number of reportable segments | Segment		9
Number of geographic segments | Segment		7
Number of new segments previously included in Other category | Segment		2
Revenue by Segment [Abstract]
Revenue		$ 623,623	$ 616,219
Other [Member]
Revenue by Segment [Abstract]
Revenue		(1,426)	235
Mainland China [Member]
Revenue by Segment [Abstract]
Revenue		208,488	197,531
Americas/Pacific [Member]
Revenue by Segment [Abstract]
Revenue		86,456	92,289
South Korea [Member]
Revenue by Segment [Abstract]
Revenue		83,853	88,930
Southeast Asia [Member]
Revenue by Segment [Abstract]
Revenue		72,495	70,860
Japan [Member]
Revenue by Segment [Abstract]
Revenue		62,109	63,224
Hong Kong/Taiwan [Member]
Revenue by Segment [Abstract]
Revenue		40,558	40,992
EMEA [Member]
Revenue by Segment [Abstract]
Revenue		41,818	44,981
Operating Segment [Member] | Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue	[1]	29,272	17,177
Operating Segment [Member] | Grow Tech [Member]
Revenue by Segment [Abstract]
Revenue		0	0
Nu Skin [Member]
Revenue by Segment [Abstract]
Revenue		594,351	599,042
Intersegment Member] | Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue		$ 5,900	$ 3,200
[1]	The Manufacturing segment had $5.9 million and $3.2 million of intersegment revenue for the three-month period ended March 31, 2019 and 2018, respectively. Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above.

Segment Information, Segment Co

Segment Information, Segment Contribution (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Segment Contribution [Abstract]
Operating income (loss)	$ 68,653	$ 58,990
Other income (expense)	(2,848)	1,207
Income before provision for income taxes	65,805	60,197
Mainland China [Member]
Segment Contribution [Abstract]
Operating income (loss)	59,167	44,817
Americas/Pacific [Member]
Segment Contribution [Abstract]
Operating income (loss)	12,019	9,172
South Korea [Member]
Segment Contribution [Abstract]
Operating income (loss)	25,668	26,201
Southeast Asia [Member]
Segment Contribution [Abstract]
Operating income (loss)	17,992	16,402
Japan [Member]
Segment Contribution [Abstract]
Operating income (loss)	14,106	13,238
Hong Kong/Taiwan [Member]
Segment Contribution [Abstract]
Operating income (loss)	7,474	7,846
EMEA [Member]
Segment Contribution [Abstract]
Operating income (loss)	1,351	4,754
Nu Skin [Member]
Segment Contribution [Abstract]
Operating income (loss)	137,777	122,430
Operating Segment [Member]
Segment Contribution [Abstract]
Operating income (loss)	137,794	120,816
Corporate and Other [Member]
Segment Contribution [Abstract]
Operating income (loss)	(69,141)	(61,826)
Manufacturing [Member] | Operating Segment [Member]
Segment Contribution [Abstract]
Operating income (loss)	3,646	(354)
Grow Tech [Member] | Operating Segment [Member]
Segment Contribution [Abstract]
Operating income (loss)	$ (3,629)	$ (1,260)

Segment Information, Depreciati

Segment Information, Depreciation and Amortization and Capital Expenditures (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Summarized Financial Information [Abstract]
Depreciation and amortization	$ 19,607	$ 18,907
Capital expenditures	13,765	12,652
Mainland China [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,116	3,487
Capital expenditures	1,681	1,869
Americas/Pacific [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	214	214
Capital expenditures	274	189
South Korea [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,524	1,667
Capital expenditures	49	0
Southeast Asia [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	477	559
Capital expenditures	94	51
Japan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,048	915
Capital expenditures	172	311
Hong Kong/Taiwan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	516	323
Capital expenditures	463	482
EMEA [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	440	176
Capital expenditures	34	35
Nu Skin [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	7,335	7,341
Capital expenditures	2,767	2,937
Corporate and Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	9,823	8,523
Capital expenditures	6,411	6,379
Manufacturing [Member] | Operating Segments [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,574	2,825
Capital expenditures	1,602	749
Grow Tech [Member] | Operating Segments [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	875	218
Capital expenditures	$ 2,985	$ 2,587

Acquisitions (Details)

Acquisitions (Details) - USD ($) $ in Thousands		Feb. 12, 2018	Jan. 22, 2018	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018	Feb. 11, 2018	Jan. 21, 2018
Fair Value of Consideration Transferred for Acquisition [Abstract]
Total cash consideration				$ 32,235
Shares issued in conjunction with acquisition				100,115
Total consideration				132,350
Previously held equity interest in equity method	[1]			39,029
Total				171,379
Gain on step acquisition				0	$ 13,644
Carrying value of investments		$ 25,400
Fair Value of Assets Acquired [Abstract]
Goodwill				$ 196,573		$ 196,573
Nutritional Product Manufacturer [Member]
Acquisitions [Abstract]
Percentage of acquired entity held by third party			8.00%
Innuvate [Member]
Acquisitions [Abstract]
Percentage of entity acquired			73.00%
Ownership interest in equity method investment								27.00%
Fair Value of Consideration Transferred for Acquisition [Abstract]
Total cash consideration			$ 17,587
Shares issued in conjunction with acquisition			5,863
Total consideration			23,450
Previously held equity interest in equity method	[1]		8,748
Total			32,198
Fair Value of Assets Acquired [Abstract]
Total current assets			6,219
Fixed assets			9,291
Total current liabilities			(3,942)
Other non-current liabilities			0
Total identifiable net assets acquired			17,768
Goodwill			17,230
Fair value of noncontrolling interest			(2,800)
Total consideration and value to be allocated to net assets			32,198
Innuvate [Member] | Customer List [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets			5,100
Useful life				9 years
Innuvate [Member] | Order Backlog [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets			200
Useful life				5 months
Innuvate [Member] | Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets			$ 900
Useful life				7 years
Innuvate [Member] | Nutritional Product Manufacturer [Member]
Acquisitions [Abstract]
Percentage of entity acquired			92.00%
Treviso [Member]
Acquisitions [Abstract]
Percentage of entity acquired		65.00%
Ownership interest in equity method investment							35.00%
Fair Value of Consideration Transferred for Acquisition [Abstract]
Total cash consideration		$ 14,648
Shares issued in conjunction with acquisition		69,252
Total consideration		83,900
Previously held equity interest in equity method	[1]	30,281
Total		114,181
Fair Value of Assets Acquired [Abstract]
Total current assets		19,659
Fixed assets		33,282
Total current liabilities		(3,740)
Other non-current liabilities		0
Total identifiable net assets acquired		71,701
Goodwill		42,480
Total consideration and value to be allocated to net assets		114,181
Treviso [Member] | Customer List [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		16,500
Useful life				9 years
Treviso [Member] | Order Backlog [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		4,700
Useful life				10 months
Treviso [Member] | Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		$ 1,300
Useful life				6 years
L&W Holdings [Member]
Acquisitions [Abstract]
Percentage of entity acquired		100.00%
Fair Value of Consideration Transferred for Acquisition [Abstract]
Total cash consideration		$ 0
Shares issued in conjunction with acquisition		25,000
Total consideration		25,000
Previously held equity interest in equity method		0
Total		25,000
Fair Value of Assets Acquired [Abstract]
Total current assets		7,353
Fixed assets		114
Total current liabilities		(1,495)
Other non-current liabilities		(1,731)
Total identifiable net assets acquired		12,241
Goodwill		12,759
Total consideration and value to be allocated to net assets		25,000
L&W Holdings [Member] | Customer List [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		6,500
Useful life				7 years
L&W Holdings [Member] | Order Backlog [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		900
Useful life				4 months
L&W Holdings [Member] | Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets		$ 600
Useful life				5 years
[1]	The acquisitions of Innuvate and Treviso are considered step acquisitions, and accordingly, the Company remeasured its pre-existing 27% equity interest in Innuvate and 35% of Treviso immediately prior to completion of the acquisition to its estimated fair value of approximately $39.0 million. As a result of the remeasurement, the Company recorded a gain of approximately $13.6 million within other income (expense), during the first quarter of 2018, representing the excess of the approximate $39.0 million estimated fair value of its pre-existing 27% equity interest in Innuvate and 35% equity interest of Treviso over its transaction date carrying value of approximately $25.4 million.

Restructuring (Details)

Restructuring (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019USD ($)
Restructuring [Abstract]
Non-cash impairment charges	$ 48,600
Cash charges associated with restructuring	22,100
Employee severance	20,100
Other related restructuring charges	2,000
Restructuring Reserve [Roll Forward]
Beginning balance	15,462
Amounts paid	(15,046)
Adjustments	(416)
Ending balance	$ 0